Molecular Cancer Therapeutics

Published by: American Association for Cancer Research  

People

  1. Lilja
    Lilja
  2. Anand
    Anand
  3. Danila
    Danila
  4. De Stanchina
    De Stanchina
  5. Fleisher
    Fleisher
  6. Furberg-Barnes
    Furberg-Barnes
  7. Gonzalez-Espinoza
    Gonzalez-Espinoza
  8. Hamelers
    Hamelers
  9. Hamlin
    Hamlin
  10. Heller
    Heller

Groups

  1. Population Sciences Research Program (5)
  2. Department of Medicine (3)
  3. Epidemiology and Biostatistics (3)
  4. Body Imaging Service (2)
  5. Epidemiology Service (2)
  6. GSK Faculty (2)
  7. Genitourinary Oncology Service (2)
  8. Radiology, Department of (2)
  9. Solid Tumor Oncology Division (2)
  10. Surgery (2)
Search Within
  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Population Sciences Research Program (5)
  2. Department of Medicine (3)
  3. Epidemiology and Biostatistics (3)
  4. Body Imaging Service (2)
  5. Epidemiology Service (2)
  6. GSK Faculty (2)

More Groups

People
  1. Hans Lilja (2)
  2. Anna Furberg-Barnes (1)
  3. Ariela Noy (1)
  4. Aseem Anand (1)
  5. Barbara Macgregor-Cortelli (1)
  6. Carol Portlock (1)

More People

Years
  1. 2019 (1)
  2. 2015 (1)
  3. 2007 (2)
  4. 2004 (1)
Publishers
  1. American Association for Cancer Research (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting nucleotide excision repair defects in cancer
    Meeting Abstract

    Topka, S.; Steinsnyder, Z.; Tkachuk, K.; Ravichandran, V.; Madsen, M. W.; Furberg-Barnes, H.; Iyer, G.; De Stanchina, E.; Joseph, V.; Offit, K.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Enhanced GAB2 expression is associated with improved survival in high-grade serous ovarian cancer and sensitivity to PI3K inhibition
    Journal Article

    Davis, S. J.; Sheppard, K. E.; Anglesio, M. S.; George, J.; Traficante, N.; Fereday, S.; Intermaggio, M. P.; Menon, U.; Gentry-Maharaj, A.; Lubinski, J.; more...
    Molecular Cancer Therapeutics (2015)

    Fulltext@MSK | Save
  • A phase '2-1-2' study of two different doses and schedules of pralatrexate, a high affinity substrate for the reduced folate carrier (RFC-1), in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies
    Meeting Abstract

    O'Connor, O. A.; Hamlin, P.; Portlock, C.; Moskowitz, C.; Noy, A.; Straus, D.; Dumetrescu, O.; Sarasohn, D.; Neylon, E.; Hamelers, R.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Circulating tumor cells as prognostic biomarkers in patients with metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Heller, G.; Leversha, M. A.; Lilja, H.; Gonzalez-Espinoza, R.; Anand, A.; Larson, S.; Schwartz, L. H.; Fleisher, M.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer
    Journal Article

    Janssen, S.; Jakobsen, C. M.; Rosen, D. M.; Ricklis, R. M.; Reineke, U.; Christensen, S. B.; Lilja, H.; Denmeade, S. R.
    Molecular Cancer Therapeutics (2004)

    Fulltext@MSK | Save

    • Molecular Cancer Therapeutics – authorized name for:

    Name ISSN / ISBN Publisher
    Molecular Cancer Therapeutics 15388514 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15388514 American Association for Cancer Research
    Molecular cancer therapeutics 15388514 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 Unknown
    Molecular Cancer Therapeutics 15357163 The Authors the American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 Unknown
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research